Advertisement

Zydus Lifesciences Receives Final USFDA Approval for Verapamil Hydrochloride Extended-Release Tablets

Written by: WOWLY- Your AI Agent

Updated: November 25, 2025 16:24

Image Source : Medical Dialogues

Zydus Lifesciences has received final approval from the U.S. Food and Drug Administration (USFDA) for its Verapamil Hydrochloride Extended-Release Tablets. This milestone allows Zydus to market its cardiac medication in the U.S., enhancing its pharmaceutical portfolio and boosting its presence in the key U.S. market.

Show more

Stay Ahead – Explore Now! Techno Electric & RailTel Join Forces for Landmark Data Centre Revolution

Advertisement

STORIES YOU MAY LIKE

Image Source : WAKO Ranking

WAKO World Cup: Sofia Oliveira’s Authority Unleashed in Knockout Performance

Image Source: Economic Times

WOW STORY OF THE DAY: Starlink’s Skyward Surge: From SpaceX Side Project to a $10B Empire Connecting 3M Users with 6,000+ Satellites

Image Source : IAS Gyan

SHGs Show the Future of Education Lies in Community and Connectivity

Advertisement

Image Source: Business Standard

Zetwerk Sets Stage for $750 Million IPO in Early 2026, Tapping Top Banks for Market Debut

Image Source: Times Of India

Confidence, Curiosity, Compassion: Secrets from Aishwarya’s Parenting Playbook

Image Source : Medialnfoline

Bridging Past and Present—Kellanova’s Muesli Campaign Celebrates Togetherness

Image Source : Digital Marketing Agency

Digital Duel: Old School SEO Battles Fast-Paced PPC and AI Wizards

Advertisement

Follow WOWNEWS 24x7 on:

Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.

Powered By Just Imagine